STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 59 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $71,000 | +14.5% | 25,659 | +0.3% | 0.00% | – |
| Q4 2020 | $62,000 | +37.8% | 25,591 | +20.5% | 0.00% | – |
| Q3 2020 | $45,000 | -45.1% | 21,239 | -2.2% | 0.00% | – |
| Q2 2020 | $82,000 | +105.0% | 21,721 | +1.4% | 0.00% | – |
| Q1 2020 | $40,000 | -14.9% | 21,424 | -5.5% | 0.00% | – |
| Q4 2019 | $47,000 | -14.5% | 22,662 | -0.8% | 0.00% | – |
| Q3 2019 | $55,000 | -23.6% | 22,853 | -0.7% | 0.00% | – |
| Q2 2019 | $72,000 | -54.7% | 23,012 | +28.5% | 0.00% | -100.0% |
| Q1 2018 | $159,000 | +31.4% | 17,911 | +7.6% | 0.00% | – |
| Q4 2017 | $121,000 | +19.8% | 16,640 | +13.2% | 0.00% | – |
| Q3 2017 | $101,000 | +4.1% | 14,697 | +8.1% | 0.00% | – |
| Q2 2017 | $97,000 | – | 13,599 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 8,083,442 | $22,310,000 | 14.49% |
| AIGH Capital Management LLC | 2,194,173 | $6,056,000 | 1.27% |
| Worth Venture Partners, LLC | 550,196 | $1,519,000 | 0.74% |
| Stonepine Capital Management, LLC | 445,701 | $1,230,000 | 0.66% |
| NEA Management Company, LLC | 4,141,308 | $11,430,000 | 0.26% |
| Ikarian Capital, LLC | 1,160,450 | $3,203,000 | 0.11% |
| ALGERT GLOBAL LLC | 99,397 | $274,000 | 0.09% |
| Zebra Capital Management LLC | 24,039 | $66,000 | 0.07% |
| HighVista Strategies LLC | 28,432 | $79,000 | 0.06% |
| Orbimed Advisors | 1,744,669 | $4,815,000 | 0.04% |